{
  "id": [
    "29849451"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "29849451"
  ],
  "pmcid": [
    "PMC5965372"
  ],
  "doi": [
    "10.2147/DDDT.S149307"
  ],
  "title": [
    "Vicenin-2 inhibits Wnt/β-catenin signaling and induces apoptosis in HT-29 human colon cancer cell line."
  ],
  "authorString": [
    "Yang D, Zhang X, Zhang W, Rengarajan T."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Yang D"
          ],
          "firstName": [
            "Dong"
          ],
          "lastName": [
            "Yang"
          ],
          "initials": [
            "D"
          ],
          "affiliation": [
            "Department of Anorectal Surgery, The First People's Hospital of Lianyungang, Lianyungang, China."
          ]
        },
        {
          "fullName": [
            "Zhang X"
          ],
          "firstName": [
            "Xiling"
          ],
          "lastName": [
            "Zhang"
          ],
          "initials": [
            "X"
          ],
          "affiliation": [
            "Department of Anorectal Surgery, Shaanxi Provincial People's Hospital, Shaanxi, Xi'an, China."
          ]
        },
        {
          "fullName": [
            "Zhang W"
          ],
          "firstName": [
            "Wencun"
          ],
          "lastName": [
            "Zhang"
          ],
          "initials": [
            "W"
          ],
          "affiliation": [
            "Department of Anorectal Surgery, The Fourth Hospital of Yu Lin City, Shaanxi Province, China."
          ]
        },
        {
          "fullName": [
            "Rengarajan T"
          ],
          "firstName": [
            "Thamaraiselvan"
          ],
          "lastName": [
            "Rengarajan"
          ],
          "initials": [
            "T"
          ],
          "affiliation": [
            "Scigen Research and Innovation, Periyar Technology Business Incubator, Thanjavur, Tamil Nadu, India."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "volume": [
        "12"
      ],
      "journalIssueId": [
        "2634220"
      ],
      "dateOfPublication": [
        "2018 "
      ],
      "monthOfPublication": [
        "0"
      ],
      "yearOfPublication": [
        "2018"
      ],
      "printPublicationDate": [
        "2018-01-01"
      ],
      "journal": [
        {
          "title": [
            "Drug design, development and therapy"
          ],
          "ISOAbbreviation": [
            "Drug Des Devel Ther"
          ],
          "medlineAbbreviation": [
            "Drug Des Devel Ther"
          ],
          "NLMid": [
            "101475745"
          ],
          "ISSN": [
            "1177-8881"
          ],
          "ESSN": [
            "1177-8881"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2018"
  ],
  "pageInfo": [
    "1303-1310"
  ],
  "abstractText": [
    "Background:Colorectal cancer (CRC) is among highest prevailing cancers in the whole world, especially in western countries. For a diverse of reasons, patients prefer naturally occurring dietary substances over synthetic agents to prevent cancer. Vicenin-2 is largely available in a medicinal plant Ocimum sanctum and is an apigenin form, 6,8-di-C-glucoside, which has been reported to have a range of pharmacological values which includes antioxidant, hepatoprotective, anti-inflammatory and anti-cancer. This study was aimed to analyze the anti-proliferative effect of Vicenin-2 on human colon cancer cells via the Wnt/β-catenin signaling inhibition. Methods:MTT assay was used to assess the cell viability at different concentrations and time point. Vicenin-2 at a concentration of 50 µM (IC50) decreased the phosphorylated (inactive) glycogen synthase kinase-3β, cyclin D1, and non-p-β-catenin expressions in HT-29 cells, which were evidenced through western blot analysis. Results:Further, Vincenin-2 reduced the T-cell factor (TCF) / Leukocyte erythroid factor (LEF) reporter activity in HT-29 cells. Vicenin-2 also promoted substantial cell cycle arrest at the G2M phase of HT-29 cells, as well induced apoptosis in HT-29 cells, as revealed through flow cytometric analysis. Furthermore, immunoblot analysis showed that Vicenin-2 treatment enhanced the expression of Cytochrome C, Bax and caspase-3 whereas suppressed the Bcl-2 expression. Conclusion:Together, these results revealed that Vicenin-2 can act as a potent inhibitor of HT-29 cell proliferation and can be used as an agent against CRC."
  ],
  "affiliation": [
    "Department of Anorectal Surgery, The First People's Hospital of Lianyungang, Lianyungang, China."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic-eCollection"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "HT29 Cells"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Tumor Cells, Cultured"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Colorectal Neoplasms"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Apigenin"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Glucosides"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antineoplastic Agents, Phytogenic"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Apoptosis"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cell Proliferation"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cell Survival"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Structure-Activity Relationship"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Dose-Response Relationship, Drug"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "beta Catenin"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AI"
                  ],
                  "qualifierName": [
                    "antagonists & inhibitors"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Wnt Signaling Pathway"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Apoptosis",
        "Caspase-3",
        "Colorectal Cancer",
        "Β-catenin",
        "Vicenin-2"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Glucosides"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Antineoplastic Agents, Phytogenic"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "beta Catenin"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "apigenin-6,8-di-C-glycopyranoside"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Apigenin"
          ],
          "registryNumber": [
            "7V515PI7F6"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC5965372?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC5965372"
          ]
        },
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.2147/DDDT.S149307"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "1"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by-nc"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2018-10-29"
  ],
  "dateOfCreation": [
    "2018-06-01"
  ],
  "dateOfRevision": [
    "2018-10-29"
  ],
  "electronicPublicationDate": [
    "2018-05-18"
  ],
  "firstPublicationDate": [
    "2018-05-18"
  ]
}